Inventor
HAGIWARA MASATOSHI
JP22 patents
⚠️ This page may combine multiple inventors who share the name “HAGIWARA MASATOSHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV KYOTO
7 patentsUS11318126B2May 3, 2022
Composition for activating neurogenesis
UNIV KYOTO2 citations71
US9745323B2Aug 29, 2017
Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor
UNIV KYOTO3 citations68
US10017524B2Jul 10, 2018
Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor
UNIV KYOTO0 citations47
US12023338B2Jul 2, 2024
Pharmaceutical composition and treatment method for genetic disease associated with splicing abnormalities
UNIV KYOTO0 citations43
US9879014B2Jan 30, 2018
Method for screening substance capable of inhibiting abnormal splicing causative of onset or progress of disease
UNIV KYOTO0 citations41
US12138253B2Nov 12, 2024
Tumor suppression
UNIV KYOTO0 citations39
US9745275B2Aug 29, 2017
Pain-related compound and medical composition
UNIV KYOTO0 citations37
HAGIWARA MASATOSHI
5 patentsUS7569536B2Aug 4, 2009
Method for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity
HAGIWARA MASATOSHI10 citations82
US9273364B2Mar 1, 2016
Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in mammalian organisms
HAGIWARA MASATOSHI3 citations70
US8816089B2Aug 26, 2014
Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity
HAGIWARA MASATOSHI0 citations50
US8338362B2Dec 25, 2012
Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity
HAGIWARA MASATOSHI0 citations50
US9241929B2Jan 26, 2016
Prophylactic or ameliorating agent for genetic diseases
HAGIWARA MASATOSHI0 citations45
FUJITSU TEN LTD
3 patentsKINOPHARMA INC
2 patentsUS7786151B2Aug 31, 2010
Therapeutic composition of treating abnormal splicing caused by the excessive kinase induction
KINOPHARMA INC20 citations91
US7928283B2Apr 19, 2011
Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in nematodes
KINOPHARMA INC2 citations51